Free Trial

Alethia Young Analyst Performance

Analyst at William Blair

Alethia Young is a stock analyst at William Blair in the healthcare sector, covering 36 publicly traded companies. Over the past year, Alethia Young has issued 12 stock ratings, including and buy recommendations. While full access to Alethia Young's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Alethia Young's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
214 Last 12 Years
Buy Recommendations
83.02% 176 Buy Ratings
Companies Covered
36 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.0%176 ratings
Hold17.0%36 ratings
Sell0.0%0 ratings

Out of 212 total stock ratings issued by Alethia Young at William Blair, the majority (83.0%) have been Buy recommendations, followed by 17.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
94.4% of companies on NASDAQ
34 companies
NYSE
5.6% of companies on NYSE
2 companies

Alethia Young, an analyst at William Blair, currently covers 36 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
36 companies
100.0%

Alethia Young of William Blair specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
34 companies
94.4%
PHARMACEUTICALS
2 companies
5.6%

Alethia Young's Ratings History at William Blair

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
10/16/2026Initiated Coverage$22.79Outperform
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
10/16/2026Initiated Coverage$87.97Outperform
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
10/16/2026Initiated Coverage$3.19Outperform
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
10/16/2026Initiated Coverage$127.34Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
10/16/2026Initiated Coverage$33.85Outperform
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
10/16/2026Initiated Coverage$22.70Outperform
Immunome, Inc. stock logo
IMNM
Immunome
10/16/2026Initiated Coverage$17.40Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
10/16/2026Initiated Coverage$63.92Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
10/16/2026Initiated Coverage$189.26Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
10/16/2026Initiated Coverage$38.20Outperform
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
10/16/2026Initiated Coverage$14.69Outperform
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
10/16/2026Initiated Coverage$20.60Outperform